Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Omeros Corp (NQ: OMER )

19.46 USD +1.40 (+7.75%)
Official Closing Price Updated: 7:48 PM EST, Jan 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,244,900
Open 19.44
Bid (Size) 19.25 (2)
Ask (Size) 20.36 (2)
Prev. Close 18.06
Today's Range 18.68 - 20.00
52wk Range 8.500 - 25.46
Shares Outstanding 48,292,608
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Biologics License Application for Narsoplimab in HSCT-TMA Accepted for Priority Review by U.S. FDA
Omeros Corporation (Nasdaq: OMER) announced today that the Biologics License Application (BLA) for narsoplimab for the treatment of hematopoietic stem cell transplant-associated thrombotic... 
From Business Wire News Releases
Omeros to Present at the 39th Annual J.P. Morgan Healthcare Conference
Omeros Corporation (Nasdaq: OMER) today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, will present at the 39th Annual J.P. Morgan Healthcare Conference this week.... 
From Business Wire News Releases

Performance

YTD
+34.02%
+34.02%
1 Month
+31.49%
+31.49%
3 Month
+72.82%
+72.82%
6 Month
+34.58%
+34.58%
1 Year
+44.58%
+44.58%

More News

Read More
CMS Confirms Continued Separate Payment for Omeros’ FDA-Approved OMIDRIA® in Ambulatory Surgery Centers
From Business Wire News Releases
Global Acute Myeloid Leukemia Therapeutics Market Could Exceed $3.5 Billion By 2027
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Global Acute Myeloid Leukemia Therapeutics Market Could Exceed $3.5 Billion By 2027
From PR Newswire
Notable Tuesday Option Activity: CVM, OMER, FARO
Tags Stocks
From Market News Video
Omeros Submits its Biologics License Application to U.S. FDA for Narsoplimab in HSCT-TMA
From Business Wire News Releases
First Week of OMER March 19th Options Trading
Tags Stocks
From Market News Video
Analysts See 28% Upside For The Holdings of XPH
Tags ETFs
From ETF Channel
Omeros Trying To Close In On Key Technical Benchmark
From Investor's Business Daily
12 Healthcare Stocks Moving In Thursday's Pre-Market Session
Tags IMV ENLV Markets
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.